Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

Company Profiles
Target Profiles
Product Profiles

Explore BCIQ profiles by entering a company name.

REQUEST A FREE TRIAL

Anthem Inc.

Name: Anthem Inc. - BioCentury Company Profiles - BCIQ
Creator: Biocentury

Headquarters: Indianapolis, IN, United States of America

Website: http://www.antheminc.com

Year Founded: 2004

Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Jul 16, 2024

Market Access

Drug rationing coming to Part D

IRA’s restructuring of cost-sharing in the catastrophic phase could force plans to restrict utilization

BioCentury | Apr 15, 2022

Politics, Policy & Law

Congressional spotlight on McKinsey over COI could reach pharmas

Documents raise questions about McKinsey’s work for FDA, life sciences clients

BioCentury | Apr 30, 2021

Deals

April 29 Quick Takes: Illumina pushes back on EC review of Grail deal, donates tools to global initiative; plus Zhaoke, Sera, Ardelyx, Protalix-Chiesi, Moderna, Phathom, Tris-Park and more

Following last month’s 4-0 vote by the FTC to challenge Illumina’s pending $7.1 billion acquisition of Grail, the company announced that it filed an action in the General Court of

BioCentury | Feb 1, 2020

Product Development